The reverse split is a defensive move to avoid delisting, not a fundamental improvement. Monitor the stock price closely through November 9, 2026 — if it fails to hold above $1.00, Nasdaq delisting becomes a real risk. Consider the risk of further dilution if the company needs to raise capital at a low post-split price.
Price Chart
Executive Summary
Glucotrack announced a 1-for-15 reverse stock split effective August 31, 2026, intended to regain compliance with Nasdaq's $1.00 minimum bid price requirement. The split reduces outstanding shares from 11,972,157 to approximately 798,144. The company must maintain a closing bid price of at least $1.00 through November 9, 2026, or face potential delisting. This is a mechanical capital structure adjustment with no change to fundamentals, but it signals ongoing listing risk for a micro-cap with a $3M market cap and a history of negative stock drift following prior filings.
Key Facts
- 1-for-15 reverse stock split effective August 31, 2026
- Outstanding shares reduced from 11,972,157 to ~798,144
- Must maintain $1.00 minimum bid price through November 9, 2026 to avoid delisting
- Stockholders approved reverse split ratio up to 1-for-30 at August 18, 2026 annual meeting
Financial Impact
No financial impact from the split itself; shares outstanding reduced from 11,972,157 to ~798,144. The company faces delisting risk if it cannot maintain $1.00 bid price through November 9, 2026.
Risk Factors
- Failure to maintain $1.00 bid price through November 9, 2026 could lead to Nasdaq delisting
- Reverse split may not attract institutional investors as hoped
- Micro-cap with $3M market cap faces ongoing liquidity and capital-raising challenges
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-040332 |
| Document: 0001493152-26-040332-index.html | 0001493152-26-040332 |
| Document: 0001493152-26-040332.txt | 0001493152-26-040332 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 8-K | $0.4032 | awaiting T+60 | — | — |
Oct 19, 2026 7d ago | 8-K | $0.6511 | awaiting T+60 | — | — |
Oct 13, 2026 12d ago | S-1/A | $0.8873 | awaiting T+60 | — | — |
Oct 13, 2026 13d ago | 425 | $0.8873 | awaiting T+60 | — | — |
Sep 28, 2026 28d ago | 8-K | $1.74 | awaiting T+60 | — | — |
Sep 24, 2026 4w ago | 424B5 | $1.82 | awaiting T+60 | — | — |
Sep 24, 2026 4w ago | 8-K | $1.82 | awaiting T+60 | — | — |
Sep 23, 2026 4w ago | 425 | $2.03 | awaiting T+60 | — | — |
Sep 23, 2026 4w ago | 8-K | $2.03 | awaiting T+60 | — | — |
Sep 18, 2026 5w ago | 8-K | $2.30 | awaiting T+60 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers